Get startedLog in
    Picture of Corcept Therapeutics Incorporated logo

    CORT — Corcept Therapeutics Incorporated News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Corcept Therapeutics Q2 EPS USD 0.32 Vs. IBES Estimate USD 0.23

    Picture of Corcept Therapeutics Incorporated logoCorcept Therapeutics Incorporated
    29/07/2024 21:05
    Jul 29 (Reuters) - Corcept Therapeutics Q2 net income USD 35.488 million vs.
IBES estimate USD 26.2 million.
* Q2 revenue USD 163.796 million vs. IBES estimate USD 155.2 million
* Q2 cash & investments USD 492.5 million
* outlook FY revenue USD 640-670 million

    Recent news on Corcept Therapeutics Incorporated

    See all news